Arbaclofen Placarbil

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameArbaclofen Placarbil
Drug Alias NameR-baclofen - XenoPort普阿氯芬普拉卡阿巴氯芬arbaclofenum placarbilumarbaclofeno placarbilo +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-Aminobutyric Acid B Receptor agonists
TargetsGamma-Aminobutyric Acid B Receptor
Therapy Area/IndicationsAlcoholismBack PainMultiple Sclerosis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesXenoport IncArbor Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesReckitt Benckiser Pharmaceuticals IncXenoport IncIndivior Inc
Active IndicationsN/A
Inactive IndicationsAlcoholismBack PainMultiple Sclerosis +[5] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG